BioCorRx Inc
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. The company offers a substance use disorder recovery program, Beat Addiction Recovery, which includes cognitive behavioral therapy modules, peer support through a mobile application, and medication prescription from an independent treating physician; an… Read more
BioCorRx Inc (BICX) - Total Assets
Latest total assets as of September 2025: $7.53 Million USD
Based on the latest financial reports, BioCorRx Inc (BICX) holds total assets worth $7.53 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
BioCorRx Inc - Total Assets Trend (2014–2024)
This chart illustrates how BioCorRx Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
BioCorRx Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
BioCorRx Inc's total assets of $7.53 Million consist of 30.6% current assets and 69.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 22.8% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $7.85K | 2.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2014–2024)
This chart illustrates how BioCorRx Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BioCorRx Inc's current assets represent 30.6% of total assets in 2024, an increase from 5.2% in 2014.
- Cash Position: Cash and equivalents constituted 22.8% of total assets in 2024, up from 1.3% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 90.0% in 2014.
- Asset Diversification: The largest asset category is intangible assets at 2.0% of total assets.
BioCorRx Inc Competitors by Total Assets
Key competitors of BioCorRx Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Xian International Medical Investment Co Ltd
SHE:000516
|
China | CN¥9.79 Billion |
|
Meinian Onehealth Healthcare Holdings Co Ltd
SHE:002044
|
China | CN¥19.57 Billion |
|
Hengkang Medical Group Co Ltd
SHE:002219
|
China | CN¥6.55 Billion |
|
TMC Life Sciences Bhd
KLSE:0101
|
Malaysia | RM1.12 Billion |
|
Optimax Holdings Sdn Bhd
KLSE:0222
|
Malaysia | RM146.00 Million |
|
Cengild Medical Berhad
KLSE:0243
|
Malaysia | RM218.07 Million |
|
DC HEALTHCARE HOLDINGS BERHAD
KLSE:0283
|
Malaysia | RM99.33 Million |
|
Raffles Medical Group Ltd
F:02M1
|
Germany | €1.49 Billion |
BioCorRx Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - BioCorRx Inc generates 0.02x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - BioCorRx Inc is currently not profitable relative to its asset base.
BioCorRx Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.10 | 0.04 | 0.32 |
| Quick Ratio | 0.09 | 0.04 | 0.32 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-13.58 Million | $ -7.87 Million | $ -2.08 Million |
BioCorRx Inc - Advanced Valuation Insights
This section examines the relationship between BioCorRx Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 209.37 |
| Latest Market Cap to Assets Ratio | 8.42 |
| Asset Growth Rate (YoY) | -0.8% |
| Total Assets | $385.94K |
| Market Capitalization | $3.25 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values BioCorRx Inc's assets at a significant premium ( 8.42x), suggesting investors see substantial growth potential or unique competitive advantages.
Slight Asset Contraction: BioCorRx Inc's assets decreased by 0.8% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for BioCorRx Inc (2014–2024)
The table below shows the annual total assets of BioCorRx Inc from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $385.94K | -0.76% |
| 2023-12-31 | $388.89K | -49.27% |
| 2022-12-31 | $766.59K | -6.51% |
| 2021-12-31 | $819.98K | -55.12% |
| 2020-12-31 | $1.83 Million | -53.55% |
| 2019-12-31 | $3.93 Million | +526.09% |
| 2018-12-31 | $628.22K | +85.37% |
| 2017-12-31 | $338.90K | -27.95% |
| 2016-12-31 | $470.38K | -66.53% |
| 2015-12-31 | $1.41 Million | -65.58% |
| 2014-12-31 | $4.08 Million | -- |